» Articles » PMID: 35654412

PPI-Affinity: A Web Tool for the Prediction and Optimization of Protein-Peptide and Protein-Protein Binding Affinity

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2022 Jun 2
PMID 35654412
Authors
Affiliations
Soon will be listed here.
Abstract

Virtual screening of protein-protein and protein-peptide interactions is a challenging task that directly impacts the processes of hit identification and hit-to-lead optimization in drug design projects involving peptide-based pharmaceuticals. Although several screening tools designed to predict the binding affinity of protein-protein complexes have been proposed, methods specifically developed to predict protein-peptide binding affinity are comparatively scarce. Frequently, predictors trained to score the affinity of small molecules are used for peptides indistinctively, despite the larger complexity and heterogeneity of interactions rendered by peptide binders. To address this issue, we introduce PPI-Affinity, a tool that leverages support vector machine (SVM) predictors of binding affinity to screen datasets of protein-protein and protein-peptide complexes, as well as to generate and rank mutants of a given structure. The performance of the SVM models was assessed on four benchmark datasets, which include protein-protein and protein-peptide binding affinity data. In addition, we evaluated our model on a set of mutants of EPI-X4, an endogenous peptide inhibitor of the chemokine receptor CXCR4, and on complexes of the serine proteases HTRA1 and HTRA3 with peptides. PPI-Affinity is freely accessible at https://protdcal.zmb.uni-due.de/PPIAffinity.

Citing Articles

Estimating Absolute Protein-Protein Binding Free Energies by a Super Learner Model.

Chaves E, Sartori J, Santos W, Cruz C, Mhrous E, Nacimento-Filho M J Chem Inf Model. 2025; 65(5):2602-2609.

PMID: 39973292 PMC: 11898044. DOI: 10.1021/acs.jcim.4c01641.


Machine Learning-Driven Methods for Nanobody Affinity Prediction.

Feng H, Sun X, Li N, Xu Q, Li Q, Zhang S ACS Omega. 2024; 9(48):47893-47902.

PMID: 39651108 PMC: 11618429. DOI: 10.1021/acsomega.4c09718.


PPB-Affinity: Protein-Protein Binding Affinity dataset for AI-based protein drug discovery.

Liu H, Chen P, Zhai X, Huo K, Zhou S, Han L Sci Data. 2024; 11(1):1316.

PMID: 39627219 PMC: 11615212. DOI: 10.1038/s41597-024-03997-4.


Rapid response to fast viral evolution using AlphaFold 3-assisted topological deep learning.

Wee J, Wei G ArXiv. 2024; .

PMID: 39606716 PMC: 11601794.


Therapeutic peptide development revolutionized: Harnessing the power of artificial intelligence for drug discovery.

Hashemi S, Vosough P, Taghizadeh S, Savardashtaki A Heliyon. 2024; 10(22):e40265.

PMID: 39605829 PMC: 11600032. DOI: 10.1016/j.heliyon.2024.e40265.


References
1.
Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R . Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020; 5(1):213. PMC: 7511340. DOI: 10.1038/s41392-020-00315-3. View

2.
Dolinsky T, Nielsen J, McCammon J, Baker N . PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 2004; 32(Web Server issue):W665-7. PMC: 441519. DOI: 10.1093/nar/gkh381. View

3.
Rodriguez-Perez R, Vogt M, Bajorath J . Influence of Varying Training Set Composition and Size on Support Vector Machine-Based Prediction of Active Compounds. J Chem Inf Model. 2017; 57(4):710-716. PMC: 5417594. DOI: 10.1021/acs.jcim.7b00088. View

4.
Pons C, Talavera D, de la Cruz X, Orozco M, Fernandez-Recio J . Scoring by intermolecular pairwise propensities of exposed residues (SIPPER): a new efficient potential for protein-protein docking. J Chem Inf Model. 2011; 51(2):370-7. DOI: 10.1021/ci100353e. View

5.
Hill T, Shepherd N, Diness F, Fairlie D . Constraining cyclic peptides to mimic protein structure motifs. Angew Chem Int Ed Engl. 2014; 53(48):13020-41. DOI: 10.1002/anie.201401058. View